Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs : British Society for Rheumatology guideline scope
Citation
Zhao , S S , Harrison , S R , Chan , A , Clarke , N , Davis , C , Eddison , J , Gregory , W J , Jones , G T , Marzo-Ortega , H , Murphy , D J , Sandhu , V , Sengupta , R , Siebert , S , Thompson , B , Webb , D , Yates , M & Gaffney , K 2023 , ' Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs : British Society for Rheumatology guideline scope ' , Rheumatology advances in practice , vol. 7 , no. 2 , rkad039 . https://doi.org/10.1093/rap/rkad039
Rights
VC The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.